Table 3.
Types of metabolic traits of patients with gallbladder lesions
| Metabolic syndrome components | Benign gallbladder polyps (567) | Gallbladder cancer (58) | P value |
|---|---|---|---|
| Hypertension | 275 (48.5) | 34 (58.6) | 0.142 |
| Hypertension Excluding Diabetes | 230 (40.6) | 29 (50.0) | 0.165 |
| Hypertension Excluding Dyslipidemia | 152 (26.8) | 10 (17.2) | 0.113 |
| Hypertension Excluding BMI ≥ 25 | 153 (27.0) | 24 (41.1) | 0.020 |
| Diabetes | 84 (11.3) | 10 (17.2) | 0.181 |
| Diabetes Excluding Hypertension | 19 (3.4) | 5 (8.6) | 0.047 |
| Diabetes Excluding BMI ≥ 25 | 35 (6.2) | 7 (12.1) | 0.088 |
| Diabetes Excluding Dyslipidemia | 38 (6.7) | 2 (3.4) | 0.335 |
| Dyslipidemia | 239 (42.2) | 37 (63.8) | 0.002 |
| Dyslipidemia Excluding Hypertension | 116 (20.5) | 13 (22.4) | 0.726 |
| Dyslipidemia Excluding Diabetes | 213 (37.6) | 29 (50.0) | 0.064 |
| Dyslipidemia Excluding BMI ≥ 25 | 147 (25.9) | 29 (50.0) | < 0.001 |
| Dyslipidemia and Hypertension | 123 (21.7) | 24 (41.4) | 0.001 |
| Dyslipidemia and Diabetes | 26 (4.6) | 8 (13.8) | 0.003 |
| Dyslipidemia and BMI ≥ 25 | 92 (16.2) | 8 (13.8) | 0.630 |
| BMI ≥ 25 | 202 (35.6) | 13 (22.4) | 0.044 |